Title |
Pathophysiology of sepsis-induced myocardial dysfunction
|
---|---|
Published in |
Military Medical Research, September 2016
|
DOI | 10.1186/s40779-016-0099-9 |
Pubmed ID | |
Authors |
Xiuxiu Lv, Huadong Wang |
Abstract |
Sepsis-induced myocardial dysfunction is a common complication in septic patients and is associated with increased mortality. In the clinical setting, it was once believed that myocardial dysfunction was not a major pathological process in the septic patients, at least in part, due to the unavailability of suitable clinical markers to assess intrinsic myocardial function during sepsis. Although sepsis-induced myocardial dysfunction has been studied in clinical and basic research for more than 30 years, its pathophysiology is not completely understood, and no specific therapies for this disorder exist. The purpose of this review is to summarize our current knowledge of sepsis-induced myocardial dysfunction with a special focus on pathogenesis and clinical characteristics. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 148 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 19 | 13% |
Student > Doctoral Student | 15 | 10% |
Student > Postgraduate | 14 | 9% |
Student > Master | 14 | 9% |
Researcher | 12 | 8% |
Other | 24 | 16% |
Unknown | 50 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 63 | 43% |
Immunology and Microbiology | 7 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
Veterinary Science and Veterinary Medicine | 4 | 3% |
Nursing and Health Professions | 4 | 3% |
Other | 13 | 9% |
Unknown | 51 | 34% |